fbpx

Kurashiki, Okayama, Japan and Utrecht, the Netherlands, 20 August 2019.

Kawasaki Medical University, Yokohama’s research hub for state-of-the-art medical science and services has acquired an ultra-high-resolution E-Class U-SPECT6/CT system for preclinical imaging. E-Class stands for “Economical Excellence” and is based on MILabs’ award-winning* generation of broadband photon tomography. It is the only nuclear imaging system that can image mice with the same visual acuity as can be obtained from imaging humans with clinical scanners.

Kawasaki Medical University installs MILabs E-Class

Prof. M. Inubushi and Dr. A. Mimura with their new U-SPECT6/CT system
(*Commercial Innovation of the Year at the WMIC 2018 Congress)

Prof. Masayuki Inubushi, principal nuclear medicine investigator and a Japanese opinion leader in molecular imaging states: “If we expect to see structures in a mouse that we are used to see in human imaging, we will need to achieve comparable anatomical and functional resolution. Today, this resolution can only be achieved with a MILabs U-SPECT/CT system”.

Prof. Frederik Beekman, founder and CEO/CTO of MILabs comments: “We are grateful that our system can contribute to the pioneering translational research work of Prof. Inubushi. Among his past accomplishments are the first off simultaneous imaging of co-injected PET/SPECT complementary oncology tracers on a MILabs VECTor PET-SPECT-CT installed at the National Institute for Radiological Sciences in Japan”.

About Kawasaki Medical University:

Located in Kurashiki in the western Okayama Prefecture, Kawasaki Medical School is a privately owned research hub for state-of-the-art medical science and medical services. Through inter-Japanese as well as international collaborations and persistent research efforts, Kawasaki’s medical research department maintains a leading role in the elucidation of the pathological conditions of intractable and unknown diseases. For more information, visit: https://m.kawasaki-m.ac.jp/en/.

About MILabs B.V.

This fast-growing Dutch company has a history of providing a continuum of innovations to expand the applications preclinical molecular imaging. With its latest adaptive platform, MILabs has succeeded at commercializing a scalable imaging platform, able to accommodate PET, SPECT, Optical & X-ray Tomography either as stand-alone or fully integrated modalities on a single integrated system. For the commercialization of this preclinical imaging platform, MILabs was awarded the Innovation of the Year 2018 by the World Molecular Imaging Society. For more information, visit:  www.milabs.com or contact MILabs at [email protected]

Share on social media
Share on facebook
Share on twitter
Share on linkedin
Share on email

Spotlight on the Orthopedic Imaging at UMC Utrecht, the Netherlands – Prof. Harrie Weinans & Dr. Bart van der Wal

  – Spotlight on the Orthopedic Imaging at UMC Utrecht, the Netherlands –  – Prof. …

Read More →

Press Release: MILABS launches its 7th generation of preclinical imagers at the World Molecular Imaging Conference 2021

Under the new ownership of the Rigaku Group (Tokyo, Japan), MILabs is pushing the value …

Read More →

Press Release: RIGAKU Acquires Life Science Imaging Equipment Manufacturer MILabs

August 3, 2021 – Houten, the Netherlands Dear readers, We are very excited that MILabs …

Read More →

Press Release: Confocal PET Causes Spectral PET Breakthrough in Preclinical Imaging

Houten, the Netherlands – March 24, 2021 Using its unique Confocal PET technology, MILabs B.V …

Read More →

Spotlight on Akiva Mintz, MD, Ph.D. – Columbia University

Spotlight on Akiva Mintz, MD, Ph.D. – Columbia University – Bridging the “valley of death” …

Read More →

Spotlight on Bart Cornelissen, PhD – Department of Oncology, Oxford Institute for Radiation Oncology at University of Oxford

– Targeting Tumors from the inside –   Dr. Bart Cornelissen is Group Leader and …

Read More →

Spotlight on Prof. Twan Lammers – ExMI-RWTH Aachen

A Pioneering Mind in Nanomedicine and Theranostics Prof. Dr. Dr. Twan Lammers is Head of …

Read More →

Miltenyi Biotec strengthens its research capabilities for cell analysis and preclinical imaging by acquiring a MILabs’ premium Optical/CT imaging system

  Utrecht and Bergisch Gladbach, September 9, 2020 Miltenyi Biotec B.V. & Co. KG, a …

Read More →

MILabs announced the co-winners of the 2020 MILabs Image of the Year Award

September 4, 2020, Utrecht, The Netherlands Each year, at the occasion of the Annual Congress …

Read More →

Bayer AS installs top-of-the-line MILabs VECTor PET/SPECT/CT to advance its targeted alpha therapy programs

August 27, 2020, Oslo-Norway and Utrecht-The Netherlands Bayer AS has installed a state-of-the-art MILabs VECTor …

Read More →

Spotlight on Prof. Marion de Jong – Erasmus MC Rotterdam

Spotlight on Prof. Marion de Jong – Erasmus MC Rotterdam On the frontline of fighting …

Read More →

The University of Southampton enters the field of Correlative In-Vivo Imaging by Acquiring MILabs 3D/4D Optical/CT

May 12, 2020, Southampton, UK – Utrecht, the Netherlands The Faculty of Medicine, University of …

Read More →
Scroll to Top